Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial
JAMA Neurol 2022 Jun 01;79(6)565-574, MS Rafii, O Sol, WC Mobley, S Delpretti, BG Skotko, AD Burke, MN Sabbagh, SH Yuan, RA Rissman, M Pulsifer, C Evans, AC Evans, G Beth, N Fournier, JA Gray, AM Dos Santos, V Hliva, M Vukicevic, M Kosco-Vilbois, J Streffer, A Pfeifer, HH FeldmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.